Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.
J Clin Med. 2023 May 28;12(11):3725. doi: 10.3390/jcm12113725.
J Clin Med. 2023.
PMID: 37297920
Free PMC article.
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC.
Kudura K, et al. Among authors: kutzker t.
Cancers (Basel). 2021 Jul 29;13(15):3830. doi: 10.3390/cancers13153830.
Cancers (Basel). 2021.
PMID: 34359730
Free PMC article.
Item in Clipboard
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.
Kudura K, Dimitriou F, Mihic-Probst D, Muehlematter UJ, Kutzker T, Basler L, Förster R, Dummer R, Mangana J, Husmann L, Burger IA, Kreissl MC.
Kudura K, et al. Among authors: kutzker t.
Diagnostics (Basel). 2021 May 15;11(5):883. doi: 10.3390/diagnostics11050883.
Diagnostics (Basel). 2021.
PMID: 34063555
Free PMC article.
Item in Clipboard
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.
Kudura K, Ritz N, Kutzker T, Hoffmann MHK, Templeton AJ, Foerster R, Kreissl MC, Antwi K.
Kudura K, et al. Among authors: kutzker t.
Cancers (Basel). 2022 Dec 11;14(24):6095. doi: 10.3390/cancers14246095.
Cancers (Basel). 2022.
PMID: 36551581
Free PMC article.
Item in Clipboard
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.
Kudura K, Ritz N, Templeton AJ, Kissling M, Kutzker T, Foerster R, Hoffmann MHK, Antwi K, Kreissl MC.
Kudura K, et al. Among authors: kutzker t.
Cancers (Basel). 2023 Feb 28;15(5):1521. doi: 10.3390/cancers15051521.
Cancers (Basel). 2023.
PMID: 36900312
Free PMC article.
Item in Clipboard
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13, 3830.
Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC.
Kudura K, et al. Among authors: kutzker t.
Cancers (Basel). 2022 Jul 4;14(13):3268. doi: 10.3390/cancers14133268.
Cancers (Basel). 2022.
PMID: 35805065
Free PMC article.
Item in Clipboard
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.
Kudura K, Ritz N, Templeton AJ, Kutzker T, Hoffmann MHK, Antwi K, Zwahlen DR, Kreissl MC, Foerster R.
Kudura K, et al. Among authors: kutzker t.
Cancers (Basel). 2023 Nov 20;15(22):5476. doi: 10.3390/cancers15225476.
Cancers (Basel). 2023.
PMID: 38001736
Free PMC article.
Item in Clipboard
Cite
Cite